|
End-of-day quote
Shanghai S.E.
2026-09-29
|
5-day change | 1st Jan Change | ||
| 3.600 CNY | 0.00% |
|
-5.76% | -9.55% |
| Market Cap | 2.82B 421M 371M 351M 319M 597M 40.38B 603M 4.21B 1.62B 20.62B 1.58B 1.55B 66.35B | P/E 2024 |
-8.86x | P/E 2025 | -9.48x |
|---|---|---|---|---|---|
| Enterprise Value | 3.04B 453M 400M 378M 343M 643M 43.48B 650M 4.54B 1.75B 22.2B 1.7B 1.66B 71.45B | EV / Sales 2024 |
1.48x | EV / Sales 2025 | 1.79x |
| Free-Float |
68.78% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -5.76% | ||
| Current month | -11.55% | ||
| 1 month | -13.67% | ||
| 3 months | +22.03% | ||
| 6 months | -6.25% | ||
| Current year | -9.55% |
| 1 week | 3.52 |  | 3.78 |
| 1 month | 3.45 | | 4.18 |
| Current year | 2.85 | | 5.27 |
| 1 year | 2.85 | | 5.27 |
| 3 years | 2.76 | | 6.15 |
| 5 years | 2.76 | | 8.8 |
| 10 years | 2.76 | | 20.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 42 | 2021-05-12 |
Xianti Zeng
DFI | Director of Finance/CFO | 52 | 2024-09-05 |
Zhi Wei Wang
PRN | Corporate Officer/Principal | 56 | 2019-09-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Ling Dou
CHM | Chairman | 66 | 2009-01-21 |
Zhi Wei Wang
BRD | Director/Board Member | 56 | 2011-02-20 |
Ya Qi Dou
BRD | Director/Board Member | 42 | 2019-01-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -5.76% | -11.33% | -37.93% | 421M | |
| +0.03% | +1.40% | +63.31% | +120.90% | 1,056B | |
| -1.87% | -0.84% | +46.97% | +71.38% | 655B | |
| -0.98% | -0.50% | +18.25% | +77.03% | 471B | |
| -1.72% | -4.06% | +36.39% | +39.47% | 342B | |
| -0.40% | +3.83% | +22.08% | +28.82% | 277B | |
| -0.51% | -1.93% | +12.09% | +11.94% | 257B | |
| +0.75% | +2.66% | +53.72% | +56.70% | 226B | |
| -0.52% | -0.83% | +34.44% | +102.04% | 189B | |
| -0.24% | -2.76% | -28.41% | -60.92% | 170B | |
| Average | -0.56% | +0.40% | +24.75% | +40.94% | 364.33B | |
| Weighted average by Cap. | -0.68% | +1.04% | +38.90% | +70.54% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.17B 324M 286M 271M 245M 460M 31.09B 464M 3.25B 1.25B 15.87B 1.22B 1.19B 51.08B | 1.86B 278M 245M 232M 210M 394M 26.64B 398M 2.78B 1.07B 13.6B 1.04B 1.02B 43.77B |
| Net income | -317M -47.27M -41.72M -39.47M -35.79M -67.11M -4.54B -67.77M -473M -182M -2.32B -177M -174M -7.45B | -330M -49.11M -43.34M -41.01M -37.19M -69.72M -4.71B -70.41M -492M -190M -2.41B -184M -180M -7.74B |
| Net Debt | 411M 61.23M 54.03M 51.12M 46.36M 86.92M 5.88B 87.78M 613M 236M 3B 230M 225M 9.65B | 217M 32.35M 28.55M 27.01M 24.5M 45.93M 3.1B 46.38M 324M 125M 1.59B 121M 119M 5.1B |
Employees
4,832
Sector
Pharmaceuticals
Calendar
Oct. 31
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-28 | CN¥3.600 | 0.00% | 14,816,710 |
| 26-09-28 | CN¥3.600 | -0.28% | 14,389,265 |
| 26-09-24 | CN¥3.610 | -1.63% | 15,858,800 |
| 26-09-23 | CN¥3.670 | -2.91% | 24,958,161 |
| 26-09-22 | CN¥3.780 | -1.05% | 29,956,200 |
- Stock Market
- Stocks
- 600594 Stock
Select your edition
All financial news and data tailored to specific country editions
